Alan Kotok<p>Trial to Test Low-Dose Psilocybin for Mental Distress</p><p>A developer of mental health therapies from <a href="https://journa.host/tags/psychedelic" class="mention hashtag" rel="tag">#<span>psychedelic</span></a> compounds says it received <a href="https://journa.host/tags/FDA" class="mention hashtag" rel="tag">#<span>FDA</span></a> clearance for a clinical trial testing low doses of <a href="https://journa.host/tags/psilocybin" class="mention hashtag" rel="tag">#<span>psilocybin</span></a>. </p><p><a href="https://sciencebusiness.technewslit.com/?p=44595" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">sciencebusiness.technewslit.co</span><span class="invisible">m/?p=44595</span></a> </p><p><a href="https://journa.host/tags/News" class="mention hashtag" rel="tag">#<span>News</span></a> <a href="https://journa.host/tags/Science" class="mention hashtag" rel="tag">#<span>Science</span></a> <a href="https://journa.host/tags/Business" class="mention hashtag" rel="tag">#<span>Business</span></a> <a href="https://journa.host/tags/MagicMushrooms" class="mention hashtag" rel="tag">#<span>MagicMushrooms</span></a> <a href="https://journa.host/tags/ClinicalTrial" class="mention hashtag" rel="tag">#<span>ClinicalTrial</span></a> <a href="https://journa.host/tags/MentalHealth" class="mention hashtag" rel="tag">#<span>MentalHealth</span></a> <a href="https://journa.host/tags/Demoralization" class="mention hashtag" rel="tag">#<span>Demoralization</span></a> <a href="https://journa.host/tags/University" class="mention hashtag" rel="tag">#<span>University</span></a> <a href="https://journa.host/tags/Canada" class="mention hashtag" rel="tag">#<span>Canada</span></a> <a href="https://journa.host/tags/Psychoactive" class="mention hashtag" rel="tag">#<span>Psychoactive</span></a> <a href="https://journa.host/tags/LowDose" class="mention hashtag" rel="tag">#<span>LowDose</span></a></p>